8-133238956-CCCCTCGCTGGTGTGCGAGCGGCTGCGGGTG-CCCCTCGCTGGTGTGCGAGCGGCTGCGGGTGCCCTCGCTGGTGTGCGAGCGGCTGCGGGTG
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM4BP6_Very_StrongBS1BS2
The NM_006096.4(NDRG1):c.1106_1107insCACCCGCAGCCGCTCGCACACCAGCGAGGG(p.Thr360_Gly369dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00116 in 151,974 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G369G) has been classified as Likely benign.
Frequency
Consequence
NM_006096.4 inframe_insertion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NDRG1 | NM_006096.4 | c.1106_1107insCACCCGCAGCCGCTCGCACACCAGCGAGGG | p.Thr360_Gly369dup | inframe_insertion | 16/16 | ENST00000323851.13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NDRG1 | ENST00000323851.13 | c.1106_1107insCACCCGCAGCCGCTCGCACACCAGCGAGGG | p.Thr360_Gly369dup | inframe_insertion | 16/16 | 1 | NM_006096.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00116 AC: 176AN: 151856Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.000122 AC: 23AN: 188768Hom.: 0 AF XY: 0.000167 AC XY: 17AN XY: 101502
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000897 AC: 128AN: 1426454Hom.: 0 Cov.: 30 AF XY: 0.0000991 AC XY: 70AN XY: 706078
GnomAD4 genome AF: 0.00116 AC: 176AN: 151974Hom.: 2 Cov.: 32 AF XY: 0.00109 AC XY: 81AN XY: 74286
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
NDRG1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 05, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 20, 2021 | In-frame duplication of 10 amino acids in a repetitive region with no known function; Has not been previously published as pathogenic or benign to our knowledge - |
Charcot-Marie-Tooth disease type 4D Benign:1
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Jul 29, 2021 | - - |
Charcot-Marie-Tooth disease type 4 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at